U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. LYFGENIA
  1. Vaccines, Blood & Biologics

STN: 125788
Proper Name: lovotibeglogene autotemcel (lovo-cel)
Tradename: LYFGENIA
Manufacturer: bluebird bio, Inc.

Indication:

  • Treatment of patients 12 years of age or older with sickle cell disease and a history of vaso-occlusive events (VOEs).

Production Information

  • Package Insert - LYFGENIA
  • Demographic Subgroup Information- LYFGENIA
    Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Back to Top